Search

Your search keyword '"Françoise Burtin"' showing total 2 results
Start Over Author "Françoise Burtin" Publication Year Range Last 50 years
2 results on '"Françoise Burtin"'

1. Cancer du sein chez un homme souffrant d’une spondylarthrite ankylosante traitée par anti-TNF-alpha : un cas

Author

Guillaume Le Roux, Françoise Burtin, Tifenn Couchouron, Laila El Mansouri, Catherine Dugast, Aleth Perdriger, Gérard Chalès, Najia Hajjaj Hassouni, and Jean-David Albert

Subjects
musculoskeletal diseases, Gynecology, Anti tumor necrosis factor alpha, medicine.medical_specialty, Rheumatology, Anticorps monoclonal, business.industry, medicine, Anti tnf alpha, skin and connective tissue diseases, business, Tumor necrosis factor α
Abstract

Resume Les auteurs rapportent une observation de cancer du sein chez un homme de 72 ans souffrant d’une spondylarthrite ankylosante traitee pendant quatre ans par anti-TNF-alpha (infliximab, etanercept), avec un antecedent familial de cancer du sein. La rarete et la gravite du cancer du sein chez l’homme, les facteurs genetiques et le role des anti-TNF sont discutes.

Published
2009
Full Text
View/download PDF

2. Breast cancer in a male with ankylosing spondylitis treated with TNFalpha antagonists

Author

Catherine Dugast, Tifenn Couchouron, Laila El Mansouri, Aleth Perdriger, Françoise Burtin, Gérard Chalès, Jean-David Albert, Najia Hajjaj Hassouni, and Guillaume Le Roux

Subjects
Oncology, Male, medicine.medical_specialty, Genes, BRCA2, Receptors, Tumor Necrosis Factor, Etanercept, Breast Neoplasms, Male, Breast cancer, Rheumatology, Risk Factors, Internal medicine, medicine, Humans, Genetic Predisposition to Disease, Spondylitis, Ankylosing, Genetic risk, Family history, skin and connective tissue diseases, Aged, Ankylosing spondylitis, business.industry, Tumor Necrosis Factor-alpha, Incidence (epidemiology), Antibodies, Monoclonal, medicine.disease, Infliximab, Immunoglobulin G, Tumor necrosis factor alpha, business, medicine.drug
Abstract

A 72-year-old male with a 4-year history of TNFα antagonist therapy (infliximab and etanercept) for ankylosing spondylitis was diagnosed with breast cancer. He had a family history of breast cancer. The low incidence and considerable severity of breast cancer in males, genetic risk factors, and potential role for TNFα antagonist therapy are discussed.

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results